Shelter Pharma Ltd (SHELTER) — shareholding pattern, promoter holding, financials and share price
About Shelter Pharma Ltd (SHELTER)
Shelter Pharma Ltd operates in the Pharmaceuticals industry, within the Healthcare sector. It trades on the NSE as SHELTER and on the BSE under scrip code 543963. Its ISIN is INE013V01011.
Incorporated in 2007, Shelter Pharma Ltd manufactures pharma products including food supplements for animals [1]
Shelter Pharma Limited, originally Shelter Pharmacy, is a manufacturer of ayurvedic and herbal products with a strong presence in the Human and Veterinary Pharma sectors.
Originally a local business in Himmatnagar, it expanded throughout Gujarat, leveraging in-house R&D for product portfolio enhancement.
Listed peers in Pharmaceuticals: Kabra Drugs Ltd, Vivimed Labs Ltd, Vista Pharmaceuticals Ltd, Mangalam Drugs and Organics Ltd, ANG Lifesciences India Ltd, Rajnish Wellness Ltd.
Valuation & Returns
10 Jul 2026At ₹27.4 a share on 10 Jul 2026, Shelter Pharma Ltd (SHELTER) was valued at a price-to-earnings ratio of 5.05x against an industry P/E of 36.41x and a price-to-book of 0.63x on a book value of ₹43.16 per share. Solomo computes return on equity of 11.78% and return on capital employed of 15.93% from filed results.
- P/E
- 5.05x
- Industry P/E
- 36.41x
- P/B
- 0.63x
- EPS (TTM)
- ₹6.26
- Book value / share
- ₹43.16
- ROE
- 11.78%
- ROCE
- 15.93%
- ROA
- 10.72%
- Debt / equity
- 0.01x
- Dividend yield
- 1.35%
- EBITDA margin
- 17.42%
- 52-week range
- ₹23 – ₹50
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Shelter Pharma Ltd (SHELTER) reported revenue of ₹73.13 crore, net profit of ₹9.03 crore and earnings per share of ₹5.44. That compares with revenue of ₹50.64 crore and net profit of ₹7.24 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹39.84 crore and net profit ₹4.53 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 30.06 | 36.15 | 39.93 | 50.64 | 73.13 |
| Net profit (₹ cr) | 2.06 | 5.21 | 6.2 | 7.24 | 9.03 |
| EPS (₹) | 42.56 | 6.73 | 5.36 | 6.26 | 5.44 |
| Measure | 5Y | 3Y | 1Y |
|---|---|---|---|
| Sales growth | 11.00% | 19.01% | 26.59% |
| Profit growth | 146.02% | 52.05% | 16.77% |
Ownership Summary
Mar 2026As of Mar 2026, promoters hold 44.99% of Shelter Pharma Ltd (SHELTER). Market capitalisation was ₹46 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Sep 2023.
Largest disclosed public shareholders in Mar 2026: MISBAHUL MOHMED PANCHBHAI 3.56%, RIFAT MISBAH PANCHBHAI 3.23%, NURJAHA MOHAMEDYUSUF LALA 1.81%, RISHABH NAYANBHAI SHARMA 1.81%, MARIYAMBIBI MOYUSUF AKULI 1.79%, LALA MOHMADYUSUF G 1.21%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Mar 2026 | 44.99% | - | - | - | 55.01% |
| Sep 2025 | 52.32% | - | - | - | 47.68% |
| Mar 2025 | 52.32% | - | - | - | 47.68% |
| Sep 2024 | 54.97% | - | - | - | 45.03% |
| Mar 2024 | 56.89% | - | - | - | 43.11% |
| Sep 2023 | 56.89% | - | - | - | 43.11% |